Literature DB >> 25815793

Mass Spectrometric Characterization of Human Serum Albumin Adducts Formed with N-Oxidized Metabolites of 2-Amino-1-methylphenylimidazo[4,5-b]pyridine in Human Plasma and Hepatocytes.

Yi Wang1, Lijuan Peng2, Medjda Bellamri3,4, Sophie Langouët3, Robert J Turesky1.   

Abstract

2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), a carcinogenic heterocyclic aromatic amine formed in cooked meats, is metabolically activated to electrophilic intermediates that form covalent adducts with DNA and protein. We previously identified an adduct of PhIP formed at the Cys(34) residue of human serum albumin following reaction of albumin with the genotoxic metabolite 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine (HONH-PhIP). The major adducted peptide recovered from a tryptic/chymotryptic digest was identified as the missed-cleavage peptide LQQC*([SO2PhIP])PFEDHVK, a [cysteine-S-yl-PhIP]-S-dioxide linked adduct. In this investigation, we have characterized the albumin adduction products of N-sulfooxy-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (N-sulfooxy-PhIP), which is thought to be a major genotoxic metabolite of PhIP formed in vivo. Targeted and data-dependent scanning methods showed that N-sulfooxy-PhIP adducted to the Cys(34) of albumin in human plasma to form LQQC*([SO2PhIP])PFEDHVK at levels that were 8-10-fold greater than the adduct levels formed with N-(acetyloxy)-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (N-acetoxy-PhIP) or HONH-PhIP. We also discovered that N-sulfooxy-PhIP forms an adduct at the sole tryptophan (Trp(214)) residue of albumin in the sequence AW*([PhIP])AVAR. However, stable adducts of PhIP with albumin were not detected in human hepatocytes. Instead, PhIP and 2-amino-1-methyl-6-(5-hydroxy)phenylimidazo[4,5-b]pyridine (5-HO-PhIP), a solvolysis product of the proposed nitrenium ion of PhIP, were recovered during the proteolysis, suggesting a labile sulfenamide linkage had formed between an N-oxidized intermediate of PhIP and Cys(34) of albumin. A stable adduct was formed at the Tyr(411) residue of albumin in hepatocytes and identified as a deaminated product of PhIP, Y(*[desaminoPhIP])TK, where the 4-HO-tyrosine group bound to the C-2 imidazole atom of PhIP.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25815793      PMCID: PMC4437839          DOI: 10.1021/acs.chemrestox.5b00075

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  67 in total

1.  Genetically modified Chinese hamster ovary cells for investigating sulfotransferase-mediated cytotoxicity and mutation by 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine.

Authors:  R W Wu; F N Panteleakos; S Kadkhodayan; R Bolton-Grob; M E McManus; J S Felton
Journal:  Environ Mol Mutagen       Date:  2000       Impact factor: 3.216

2.  MyriMatch: highly accurate tandem mass spectral peptide identification by multivariate hypergeometric analysis.

Authors:  David L Tabb; Christopher G Fernando; Matthew C Chambers
Journal:  J Proteome Res       Date:  2007-02       Impact factor: 4.466

3.  Differential metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in rat and human hepatocytes.

Authors:  Sophie Langouët; Axel Paehler; Dieter H Welti; Nathalie Kerriguy; André Guillouzo; Robert J Turesky
Journal:  Carcinogenesis       Date:  2002-01       Impact factor: 4.944

Review 4.  Influence of tertiary structure on nucleophilic substitution reactions of proteins.

Authors:  P L Skipper
Journal:  Chem Res Toxicol       Date:  1996-09       Impact factor: 3.739

5.  Relationship of phenol sulfotransferase activity (SULT1A1) genotype to sulfotransferase phenotype in platelet cytosol.

Authors:  S Nowell; C B Ambrosone; S Ozawa; S L MacLeod; G Mrackova; S Williams; J Plaxco; F F Kadlubar; N P Lang
Journal:  Pharmacogenetics       Date:  2000-12

6.  Novel LC-ESI/MS/MS(n) method for the characterization and quantification of 2'-deoxyguanosine adducts of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by 2-D linear quadrupole ion trap mass spectrometry.

Authors:  Angela K Goodenough; Herman A J Schut; Robert J Turesky
Journal:  Chem Res Toxicol       Date:  2007-02       Impact factor: 3.739

7.  The urinary metabolite profile of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine is predictive of colon DNA adducts after a low-dose exposure in humans.

Authors:  Michael A Malfatti; Karen H Dingley; Susan Nowell-Kadlubar; Esther A Ubick; Nisha Mulakken; David Nelson; Nicholas P Lang; James S Felton; Kenneth W Turteltaub
Journal:  Cancer Res       Date:  2006-11-01       Impact factor: 12.701

8.  1H NMR of albumin in human blood plasma: drug binding and redox reactions at Cys34.

Authors:  J Christodoulou; P J Sadler; A Tucker
Journal:  FEBS Lett       Date:  1995-11-27       Impact factor: 4.124

9.  How to measure and predict the molar absorption coefficient of a protein.

Authors:  C N Pace; F Vajdos; L Fee; G Grimsley; T Gray
Journal:  Protein Sci       Date:  1995-11       Impact factor: 6.725

Review 10.  Proteomic approaches to characterize protein modifications: new tools to study the effects of environmental exposures.

Authors:  Daniel C Liebler
Journal:  Environ Health Perspect       Date:  2002-02       Impact factor: 9.031

View more
  10 in total

1.  Mass Spectrometric Characterization of an Acid-Labile Adduct Formed with 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and Albumin in Humans.

Authors:  Yi Wang; Peter W Villalta; Lijuan Peng; Karen Dingley; Michael A Malfatti; K W Turteltaub; Robert J Turesky
Journal:  Chem Res Toxicol       Date:  2017-01-18       Impact factor: 3.739

2.  PhIP exposure in rodents produces neuropathology potentially relevant to Alzheimer's disease.

Authors:  Tauqeerunnisa Syeda; Rachel M Foguth; Emily Llewellyn; Jason R Cannon
Journal:  Toxicology       Date:  2020-03-10       Impact factor: 4.221

3.  Metabolic Activation of the Cooked Meat Carcinogen 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine in Human Prostate.

Authors:  Medjda Bellamri; Shun Xiao; Paari Murugan; Christopher J Weight; Robert J Turesky
Journal:  Toxicol Sci       Date:  2018-06-01       Impact factor: 4.849

4.  Alterations in the nigrostriatal dopamine system after acute systemic PhIP exposure.

Authors:  Zeynep Sena Agim; Jason R Cannon
Journal:  Toxicol Lett       Date:  2018-01-31       Impact factor: 4.372

5.  Novel Transgenic Mouse Model for Studying Human Serum Albumin as a Biomarker of Carcinogenic Exposure.

Authors:  Jonathan Sheng; Yi Wang; Robert J Turesky; Kerri Kluetzman; Qing-Yu Zhang; Xinxin Ding
Journal:  Chem Res Toxicol       Date:  2016-04-14       Impact factor: 3.739

6.  Biomonitoring an albumin adduct of the cooked meat carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in humans.

Authors:  Medjda Bellamri; Yi Wang; Kim Yonemori; Kami K White; Lynne R Wilkens; Loïc Le Marchand; Robert J Turesky
Journal:  Carcinogenesis       Date:  2018-12-31       Impact factor: 4.944

7.  Biomonitoring Human Albumin Adducts: The Past, the Present, and the Future.

Authors:  Gabriele Sabbioni; Robert J Turesky
Journal:  Chem Res Toxicol       Date:  2016-12-18       Impact factor: 3.739

Review 8.  Quo vadis blood protein adductomics?

Authors:  Gabriele Sabbioni; Billy W Day
Journal:  Arch Toxicol       Date:  2021-11-13       Impact factor: 5.153

9.  Heterocyclic Aromatic Amines and Risk of Kidney Stones: A Cross-Sectional Study in US Adults.

Authors:  Guangyuan Zhang; Xiangyu Zou; Weipu Mao; Ming Chen
Journal:  Front Public Health       Date:  2022-07-14

Review 10.  Metabolism and biomarkers of heterocyclic aromatic amines in humans.

Authors:  Medjda Bellamri; Scott J Walmsley; Robert J Turesky
Journal:  Genes Environ       Date:  2021-07-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.